Objective: Outcome prediction in patients after cardiac arrest (CA) is challenging. Electroencephalographic reactivity (EEG-R) might be a reliable predictor. We aimed to determine the prognostic value of EEG-R using a standardized assessment. Methods: In a prospective cohort study, a strictly defined EEG-R assessment protocol was executed twice per day in adult patients after CA. EEG-R was classified as present or absent by 3 EEG readers, blinded to patient characteristics. Uncertain reactivity was classified as present. Primary outcome was best Cerebral Performance Category score (CPC) in 6 months after CA, dichotomized as good (CPC = 1-2) or poor (CPC = 3-5). EEG-R was considered reliable for predicting poor outcome if specificity was ≥95%. For good outcome prediction, a specificity of ≥80% was used. Added value of EEG-R was the increase in specificity when combined with EEG background, neurological examination, and somatosensory evoked potentials (SSEPs). Results: Of 160 patients enrolled, 149 were available for analyses. Absence of EEG-R for poor outcome prediction had a specificity of 82% and a sensitivity of 73%. For good outcome prediction, specificity was 73% and sensitivity 82%. Specificity for poor outcome prediction increased from 98% to 99% when EEG-R was added to a multimodal model. For good outcome prediction, specificity increased from 70% to 89%. Interpretation: EEG-R testing in itself is not sufficiently reliable for outcome prediction in patients after CA. For poor outcome prediction, it has no substantial added value to EEG background, neurological examination, and SSEPs. For prediction of good outcome, EEG-R seems to have added value.
patients without a chance of neurologic recovery, and to avoid unjust withdrawal of life-sustaining treatment (WLST), several diagnostic tests have been advocated. 6 Traditional markers predicting poor outcome are absent brainstem reflexes, bilateral absence of N20 responses on somatosensory evoked potentials (SSEPs), and electroencephalography (EEG) at or after 72 hours post-CA. These tests have high specificity but limited sensitivity for prediction of poor neurological outcome, ranging between 20 and 50%. 6 In recent years, early EEG background patterns at 12 and 24 hours were reported to be reliable prognostic markers for both poor and good outcome. 4, 7, 8 EEG is widely available, and there is extensive experience in many hospitals. 6, 9 Besides background patterns, the EEG response to external stimulation, that is, EEG reactivity (EEG-R), can also be assessed. [6] [7] [8] 10 Absence of EEG-R has been reported with a specificity ranging between 70 and 100% for prediction of poor outcome. 7, 8, [10] [11] [12] [13] [14] For good outcome, presence of EEG-R has been shown to result in a specificity between 55 and 95%. 7, 8 Unfortunately, protocols for EEG-R are often poorly described and vary widely, and a clear definition for interpretation of EEG-R is not available. 15 The studies performed so far have been mainly single-center studies with limited cohort sizes. Nevertheless, EEG-R in combination with other factors is included in recommendations for neurological prognostication in comatose patients after CA. 6 Given these limitations, we aimed to determine the prognostic value of EEG-R for the prediction of outcome when using a strict and replicable protocol for EEG-R testing. We aimed to determine the prognostic value of EEG-R for poor and for good neurological outcome separately, because clinical consequences are different in both situations. In patients with a high probability of poor outcome, a test confirming this might lead to WLST. In a patient with a high probability of good outcome, substantiating this would justify more invasive therapies. In addition, we investigated the additional prognostic value of EEG-R to other prognostic markers for neurological outcome. We also determined the reliability of the interpretation of EEG-R.
We hypothesized that EEG-R is a reliable tool for prediction of poor neurological outcome in patients after CA.
Patients and Methods

Design
This was an investigator-initiated prospective multicenter cohort study conducted in the ICUs of 2 Dutch universitybased hospitals and 1 teaching hospital. The institutional review board of the Amsterdam University Medical Centers, the Netherlands, approved the study protocol and waived the need for written informed consent, as EEG-R assessment and basic follow-up are part of routine monitoring in comatose patients after CA. The trial was registered at trialregister.nl (identifier: NTR6231).
Patients
Consecutive comatose adult patients after CA in whom continuous EEG (cEEG) monitoring was started within 24 hours after CA were eligible for participation. Exclusion criteria included traumatic brain injury, acute stroke, progressive neurodegenerative disease, prearrest modified Rankin scale ≥4, or prearrest life expectancy ≤6 months based on comorbidity.
Standard Care and Monitoring
Patients were treated according to local guidelines for comatose CA patients. This included targeted temperature management (TTM), aiming at 32 or 36 C, for 24 hours at all centers. cEEG monitoring was continued for 3 days unless a patient regained consciousness. Recordings were done with at least 9 electrodes, placed according to the international 10-20 system. Additionally, a ground and reference electrode were placed in the midline. EEGs were recorded with a Viasys Nicolet (CareFusion, Middleton, WI), BrainQuick ICU (Micromed, Mogliano Veneto, Italy), or Nihon Kohden system (VCM Medical, Leusden, the Netherlands). Decisions for withdrawal of life support were based on the Dutch recommendations for prognostication in postanoxic coma. 16 These include neurological examination after clearance of sedative drugs by a neurologist, SSEP testing performed after TTM, and EEG patterns at 72 hours post-CA. 6 Biomarkers are currently not advised in the Dutch guidelines.
EEG Reactivity
For the duration of cEEG monitoring, EEG-R was assessed twice per day, morning and afternoon, according to a standardized protocol of commonly used stimuli, 15 regardless of the EEG background pattern. The protocol consisted of a fixed set of auditory (clapping hands and calling out the patient's name), visual (passive eye opening), tactile (intranasal tickling of the nasal septum with a cotton swap), and noxious stimuli (sternal rub). Each stimulus was performed for 5 seconds and applied 3 times in a row with intervals of 30 seconds. The complete stimulus protocol was executed in all patients. Stimulation was stopped if a patient showed clinical signs of arousal, such as eye opening or localizing, to any of the stimuli (independent of EEG-R findings).
All EEG-R assessments were made centrally. Three experienced EEG readers (A.-F.v.R., J.Hor., and M.M.A.), blinded to the individual patient characteristics and time interval from resuscitation, independently rated EEG-R offline using a custom-made interface in MATLAB R2012b (MathWorks, Natick, MA). EEG-R was considered present if 18 Volume 86, No. 1 any of the stimuli induced a change in EEG amplitude or frequency at least twice. Artifacts due to muscle activity or other noise-and stimulus-induced rhythmic or periodic discharges were not classified as present EEG-R. Incomplete EEG-R assessments (>2 of the 15 stimuli missing not caused by arousal of the patient) and assessments obscured by artifacts were excluded from analysis. The 3 raters also scored whether they were certain or uncertain whether EEG-R was present. In the case of uncertainty, the EEG-R was considered present in the analysis, to avoid unjust pessimistic test results leading to an increased number of false positives. When the raters disagreed on reactivity, the decision as to whether EEG-R was present was based on the majority vote. As a secondary analysis, EEG-R assessments without unanimous agreement were re-evaluated in a consensus meeting.
For analysis, 1 EEG-R assessment was selected per patient. This was the first assessment scored as reactive or, if no reactive assessment was available, the EEG-R assessment where the patient received the lowest dose of sedation. If all EEG-R assessments of a patient were excluded because of incorrect execution of the protocol, artifacts, or technical reasons, the patient was excluded from analysis and we did not include an extra patient.
EEG Background Pattern
Time windows of 5 minutes of EEG recording were selected from the cEEG at 12 and 24 hours after CA and immediately before each stimulus protocol. These were scored by the 3 raters according to validated critical care EEG criteria as defined by the American Clinical Neurophysiology Society (ACNS), separated into 3 categories (A, B, and C; Table 1 ). 12 
Clinical Variables
The following clinical variables were collected: age, sex, location of CA, arrest witnessed, time to return of spontaneous circulation (ROSC), initial heart rhythm, presumed etiology of CA, and the results of SSEP recordings if performed. At the time of each EEG-R assessment, information on temperature, sedative medication, and pupillary and corneal reflexes was collected.
Outcome
Primary outcome measure was the best achieved neurological outcome within 6 months after CA, defined as good (Cerebral Performance Category score [CPC] = 1-2; no or mild cerebral impairment) or poor (CPC = 3-5; moderate cerebral impairment, vegetative state, or death). 17 Power Calculation A power calculation was performed for the primary research question: prognostic value of absent EEG-R for prediction of poor outcome. This was based on a prevalence of absent EEG-R of 45% and an expected specificity for the prediction of poor outcome of 94%, both based on pooled existing data. 7, 11, [18] [19] [20] With an alpha error of 0.05, a power of 80%, and 2-tailed testing, we needed 160 patients to reach the expected specificity level.
Statistical Analysis
The prognostic values of absence of EEG-R for prediction of poor outcome and presence of EEG-R for good outcome were described as specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV). Based on the differences in clinical implications of predicting poor or good neurological outcome, thresholds for a reliable marker for poor outcome prediction and good outcome prediction were chosen differently. EEG-R by itself was deemed a sufficiently reliable marker for poor outcome if the specificity was ≥95% with a 95% confidence interval (CI) of <5%. 6 For good outcome, on the other hand, EEG-R was deemed sufficiently reliable if the specificity was ≥80% with a 95% CI of <10%. We calculated prognostic value for both situations. CIs were calculated according to the Clopper-Pearson exact confidence interval method. 21 As a sensitivity analysis, prognostic value of EEG-R was also assessed in several time windows post-CA: <12 hours, 12 to 24 hours, 24 to 48 hours, and >48 hours post-CA. For each window, the best available score per patient was used for analysis and prognostic values for both poor and good outcome were calculated. Influence of nonneurological deaths on the prognostic value of EEG-R was assessed by excluding these cases and calculating prognostic value. Influence of sedative medication on EEG-R was assessed by comparing the proportion of patients receiving sedation and the median dose between reactive and unreactive patients.
The additional value of EEG-R to other available variables was assessed as the increase in prognostic value of a baseline multimodal prediction algorithm when EEG-R is added. For prediction of poor outcome, the baseline algorithm was EEG background category A (see Table 1 ) at 24 hours OR bilaterally absent pupillary reflexes and corneal reflexes on all tests at <72 hours OR bilaterally absent cortical N20 response on SSEP testing. For predicting good outcome, the baseline algorithm was EEG background category C (see Table 1 ) at 12 hours OR brainstem reflexes present at all tests at <72 hours.
The reliability of EEG-R interpretation was assessed by inter-and intrarater variability. Inter-rater variability among the 3 raters was assessed using intraclass correlation coefficient (ICC) and 95% CI based on an average-measures, absolute-agreement, 2-way random-effects model. For test-retest reliability, the 3 raters scored 30 randomly selected EEG-R protocols 3 times, mixed with other EEG-R assessments and in separate batches to omit recognition. Intrarater variability was assessed by ICC and corresponding 95% CI based on an average-measures, absolute-agreement, 2-way mixed-effects model.
Difference between outcome groups was described using chi-square, Fisher exact test, or Mann-Whitney U test, whichever was appropriate. Probability values <0.05 were considered statistically significant. Statistical analyses were performed using MATLAB 2012b. Missing data were not imputed.
Results
Patients
Patients were enrolled between April 2015 and February 2018. A total of 182 patients were considered eligible, and 160 patients were enrolled (see Fig 1 for details) . At the Amsterdam University Medical Centers 129 patients were enrolled, Rijnstate Hospital Arnhem included 17 patients, and University Medical Center Nijmegen included 14 patients. In these 160 patients, 426 EEG-R assessments were executed, of which 51 were excluded because of artifacts, 10 because of technical issues, and 20 because the EEG-R assessment was incomplete. The remaining 345 EEG-R assessments in 149 patients were available for analysis. Examples of present, unsure, and absent EEG-R are shown in Figure 2 .
Patient characteristics are presented in Table 2 . Seventy patients (47%) had a poor outcome (9 CPC = 3, 2 CPC = 4, 59 CPC = 5), and 79 (53%) had a good EEG-R, but had a poor outcome; 3 had CPC = 3 at 6 months and 16 died, 6 from a non-neurological cause, 9 from a neurological cause, and 1 of unknown cause. Of those 9 patients that died from a neurological cause, SSEPs were tested in 7; in 1 patient, the N20 was bilaterally absent. In the other patients, a wait and see policy was applied and treatment was withdrawn when no neurological recovery appeared (median time from CA to death = 5 days, IQR = 3.5-11 days). For presence of EEG-R predicting good outcome, we found 73% (95% CI = 62-83) specificity and 82% (95% CI = 74-91) sensitivity (see Table 3 ).
In none of the time windows after CA that we assessed did specificity for prediction of poor outcome reach our predefined limit for sufficient reliability (Table 5 ). After Data are presented as median (interquartile range) or n/n (%). For EEG pattern classification, see Table 1 . a n = 76. b n = 63. EEG = electroencephalographic; ICU = intensive care unit; OHCA = out of hospital cardiac arrest; ROSC = return of spontaneous circulation; SSEP = median nerve somatosensory evoked potential.
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Volume 86, No. 1 excluding non-neurological deaths (n = 13), the specificity for prediction of poor outcome was 82% (95% CI = 72-90) and the sensitivity was 77% (95% CI = 64-87; see Table 4 , B). Unreactive patients less often received sedative medication (Table 6 ). If sedated, dose of propofol or midazolam did not differ between reactive and unreactive patients.
Additional Prognostic Value of EEG-R
Prediction of poor neurological outcome based on EEG background at 24 hours post-CA, brainstem reflexes, or SSEPs resulted in a specificity of 98% (95% CI = 91-100) and the sensitivity of 54% (95% CI = 42-66). If also EEG-R was absent, the specificity was 99% (95% CI = 93-100) and the sensitivity was 51% (95% CI = 39-64; see Table 3 for PPV and NPV). For prediction of good neurological outcome based on EEG background at 12 hours post-CA or brainstem reflexes, the specificity was 70% (95% CI = 58-80) at 79% (95% CI = 68-87) sensitivity. When present EEG-R was added, the specificity increased to 89% (95% CI = 79-95), and the sensitivity decreased to 66% (95% CI = 54-76; see Table 3 for PPV and NPV).
Reliability of EEG-R Interpretation
Inter-rater reliability was good, with an ICC of 0.85 (95% CI = 0.82-0.88). Intrarater variability was moderate on average: rater A, ICC = 0.68 (95% CI = 0.34-0.85); rater B, ICC = 0.70 (95% CI = 0.37-0.86); rater C, ICC = 0.83 (95% CI = 0.64-0.92). In the 83 (24%) EEG-R assessments that were re-evaluated in a consensus meeting, we found poor agreement between the results of the majority vote and consensus meeting (ICC = 0.40, 95% CI = 0.09-0.61). Based on consensus meeting results, specificity and sensitivity did not change (see Table 4 , C).
Discussion
In this study, we found that EEG-R in itself is not reliable enough for prediction of poor or good neurological outcome in patients after CA. In light of the multimodal approach to prognostication, the question is to what extent Specificity, sensitivity, PPV, and NPV data are given as percentage (95% CI). For EEG, pattern classification, see Table 1 . cat. = category; CI = confidence interval; EEG = electroencephalographic; NPV = negative predictive value; PPV = positive predictive value; SSEP = somatosensory evoked potential.
July 2019 23 does EEG-R provide additional information. EEG-R seems not to be of additional value for prediction of poor outcome; it might be of additional value for prediction of good outcome. We found moderate test-retest reliability and poor agreement between majority vote and consensus meeting results. This is the first study to assess the prognostic value of standardized assessment of EEG-R in a prospective study, specifically designed for this purpose. The prognostic value of EEG-R has been described before, but mainly in studies with small sample sizes and with conflicting results. 7, 11, 18, [22] [23] [24] [25] [26] [27] [28] Two studies are available that describe large cohorts, 357 and 373 patients, with reported specificities for poor outcome of 77% (95% CI = 60-88) and 99% (95% CI = 97-100), respectively. 8, 10 We obtained a specificity of 82%. However, these studies were retrospective, protocols were less extensive and structured, and other stimuli were used. In contrast to our study, one study included bilateral nipple pinching. 8 This stimulus was described, albeit in a very small study, as the stimulus most often evoking EEG-R. 29 We deliberately did not include this stimulus, as it is under ethical debate. 29, 30 Furthermore, one study described bedside, and therefore unblinded, scoring of EEG-R, which is the opposite of our fully blinded analysis. 8 Finally, we used best CPC within 6 months compared to 3 months or at hospital discharge. Early determination of outcome could lead to an overly pessimistic estimation of outcome, as survivors recover.
Stimulation protocols between studies vary widely, and guidelines do not state which stimuli to use. 6, 15, 31 In this study, stimulations were always executed in the same order, with increasing intensity of stimulation, and the full stimulus protocol was always executed. Only clinical arousal was a reason to discontinue the protocol. The raters only scored whether they considered a complete stimulation protocol reactive, regardless of the exact stimulus type. In futures studies, best practice for performing stimulations should be investigated. Outcome was determined by the CPC scale (CPC) and dichotomized as good (CPC = 1-2) and poor (CPC = 3-5) outcome. EEG reactivity was based on majority vote (A), based on majority vote with patients dying of a non-neurological cause excluded (B), and based on consensus meeting results (C). CPC = Cerebral Performance Category; EEG = electroencephalographic. EEG-R and outcome are binary; therefore, values for prediction of good outcome are the exact opposite. Sensitivity and specificity are given as percentage (95% confidence interval). EEG-R = electroencephalographic reactivity; FN = false negative; FP = false positive; NPV = negative predictive value; PPV = positive predictive value; TN = true negative; TP = true positive.
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Ideally, the specificity of a prognostic test, when used by itself, should be 100%. We decided to aim for at least 95% before denominating it reliable. Although WLST decisions will never be made based on a single predictor, knowing the prognostic value of each predictor in the multimodal prognostication process is valuable. EEG-R was not able to reach our reliability limit, and we therefore do not find it sufficiently reliable to be used by itself. For good outcome prediction, we set a slightly wider limit (at least 80% specificity), because implications are less drastic, but even this limit could not be reached. The sensitivity of EEG-R, on the other hand, is much higher than other clinical tests for prediction of outcome. 6 However, especially for poor outcome, specificity is the main determinant of a reliable marker. EEG-R by itself should therefore be used with great caution. Although only one clinical assessment (EEG-R) is performed, we report prognostic values of both poor and good. In our opinion, knowing the predictive value of a test for both poor and good outcome facilitates a balanced decision in clinical practice.
Because prognostication after CA is often executed multimodally, we also assessed the prognostic value of EEG-R in addition to clinical examination, assessment of SSEPs, and EEG background patterns. Including EEG-R did not result in a clinically relevant increase of the specificity for prediction of outcome. Therefore, we cannot conclude that EEG-R is of additional value. For prediction of good outcome, however, specificity increased substantially, and therefore EEG-R might be of added value. The increase in specificity was at the cost of a decrease in sensitivity.
In our cohort, several patients died in the ICU from a non-neurological cause. This could have decreased our sensitivity for prediction of poor outcome, as EEG-R is primarily used for prediction of poor neurological outcome. When these patients were analyzed as having a good outcome, sensitivity and specificity did not change, and therefore this had no major influence on our results. The reliability of the visual assessment of EEG-R was previously described as questionable. 32, 33 We thoroughly assessed the reliability and investigated inter-rater agreement, but also test-retest reliability and comparison between majority vote and consensus meeting results. The moderate test-retest reliability and poor agreement between majority vote and consensus meeting are not in favor of using EEG-R in prognostication after CA. Part of the problem might be the poorly described definition of EEG-R. The ACNS defined EEG-R as "Change in cerebral activity to stimulation." 31 This can be any change in amplitude and/or frequency, including attenuation of activity. The ACNS definition is open to multiple interpretations, and there are no cutoffs in terms of frequency or amplitude change for reactivity. Also, these guidelines do not state the time window in which a change in the EEG should be seen to qualify as reactive. In our study, we assumed a reactive EEG to show changes within several seconds after stimulation. We evaluated EEG-R per stimulus and did not assess the change in EEG before stimulations were started compared to after all stimuli were executed. This approach has been used before, for example, in studies by the group of Rossetti. 8 In line with the ACNS definition, we excluded muscle artifact from EEG-R. We note that a reaction to stimulation is potentially not limited to a change in the EEG or the frequency band we investigated. This should be evaluated in future studies. The variability of the human interpretation of EEG-R could be overcome by quantitative analysis; however, no algorithm is currently available for clinical application. 13, 25, 32, 34 A first step toward a clearer definition could be determining thresholds for changes based on EEG-R assessments where the decision between reactive and unreactive was unanimous. For this purpose, assessments scored as uncertain could be left out. Results are given as n/total (percentage of total) or median (interquartile range). For analysis, 1 EEG-R assessment was selected per patient. This was the first assessment scored as reactive or, if no reactive assessment was available, the EEG-R assessment where the patient received the lowest dose of sedation. Four of the reactive patients and 5 of the unreactive patients received both propofol and midazolam. EEG-R = electroencephalographic reactivity.
Another feature of the EEG that has been studied in the context of outcome prediction in comatose patients is spontaneous EEG variability. 35 In comatose patients with varying etiologies, typically, less spontaneous variability is associated with worse outcomes. [35] [36] [37] Possibly, spontaneous variability of the EEG, complementary to the stimulus-induced EEG-R, increases diagnostic accuracy.
Strengths and Limitations
Major strengths of this study are the prospective design, properly performed a priori power calculation, and blinding of the EEG readers to outcome, patients' clinical status, and other information such as resuscitation details. Furthermore, our follow-up was long, allowing patients to recover. Primary outcome was best CPC as opposed to CPC at a certain time point to prevent an overly pessimistic outcome estimation. We limited the influence of selffulfilling prophecy by not notifying the treating physicians of the results of EEG-R testing. The early EEG background as measured by the cEEG was not part of our multimodal decision protocol on prognostication, nor was EEG-R. WLST was performed in a third of patients with poor outcome, but the moment of these decisions was not registered. A bilateral absence of the cortical N20 with the SSEPs resulted in WLST. If the N20 was not bilaterally absent, a wait and see policy was used. Our study has several limitations. Not all 160 patients deemed necessary could be analyzed, as data from 11 patients could not be used. Both the expected specificity as used in our power calculation and the threshold for a reliable predictor could not have been reached if additional patients were included and 160 analyzable patients were reached.
One center was over-represented in the study. This could limit generalizability of our results. Another limitation is that video recordings were not included in the EEG registration. In almost one-quarter of the EEG-R assessments, raters were uncertain of reactivity for instance in establishing actual EEG-R or muscle or movement artifacts. Possibly, video recordings and/or administration of muscle relaxants could improve reliable assessment. According to our protocol for EEG-R testing, stimulations could be stopped when the patient shows clinical signs of arousal. This could unblind EEG readers and therefore be a potential source of bias. In our study, clinical signs of arousal led to stopping the stimulations in only 1% of the sample and is therefore unlikely to have imposed a bias on the results.
Conclusion
Our findings suggest that EEG-R by itself is not a reliable predictor for either poor or good outcome in comatose patients after CA. In addition to clinical examination, SSEPs, and EEG background pattern, we found no additional value of EEG-R. For prediction of good neurological outcome, EEG-R increased specificity substantially. However, reliable assessment of EEG-R remains an issue. Although our data do not support the use of EEG-R for poor outcome prediction in patients after CA, it may have added value for prediction of good outcome.
